Literature DB >> 11943494

Estrogen-alpha and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch.

H De Bosschere1, R Ducatelle, H Vermeirsch, P Simoens, M Coryn.   

Abstract

Estrogen-alpha receptor (ER) and progesterone receptor (PR) were examined immunohistochemically in uteri of normal bitches, in uteri of bitches with cystic endometrial hyperplasia-mucometra (CEH-M) and in uteri of bitches with endometritis-pyometra (E-P), under exogenous progesterone treatment. In the CEH-M group, the ER- and PR-scores of all uterine cell types were higher than the ER- and PR-scores of normal uteri, although these differences were not always statistically significant. The ER-scores of E-P group were significantly lower than the ER-scores of the normal uteri and CEH-M group. The PR-scores of the E-P group tended to be higher than the PR-scores of the normal uteri, except for the surface epithelium, although these differences were not statistically significant. Exogenous progesterone treated bitches with CEH-M or E-P showed reduced ER- and PR-scores in the different uterine cell types, compared with the corresponding nontreated CEH-M or E-P group. The differences in ER and PR expression between CEH-M and E-P suggest different factors in the pathogenesis of both entities. Although, these changes in ER and PR expression do not seem to be directly involved in the pathogenesis of CEH-M and E-P. It is suggested that for CEH-M and progestin induced CEH-M a hormone dependent pathway is responsible. For P, the trigger may be bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943494     DOI: 10.1016/s0378-4320(02)00013-1

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  1 in total

1.  The use of epostane in an attempt to reproduce cystic endometrial hyperplasia in the bitch.

Authors:  H De Bosschere; R Ducatelle; M Tshamala; M Coryn
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.